Other Species / Isoforms
  DFFA (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
G8
MEVTGDAGVPESGEI
0 1
DFFA (human) MEVTGDAGVPESGEI G8
DFFA iso2 (human) MEVTGDAGVPESGEI G8
DFFA (mouse) MELSRGAsAPDPDDV S8-p
DFFA iso2 (mouse) MELSRGASAPDPDDV S8
DFFA (rat) MELSRGASAPDPDDV S8
Y27-p
PCLLRRNysREQHGV
0 1
DFFA (human) PCLLRRNysREQHGV Y27-p
DFFA iso2 (human) PCLLRRNYsREQHGV Y27
DFFA (mouse) PCLLRRNHsRDQHGV H27
DFFA iso2 (mouse) PCLLRRNHSRDQHGV H27
DFFA (rat) PCLLRRNHSREQHGV H27
S28-p
CLLRRNysREQHGVA
0 15
DFFA (human) CLLRRNysREQHGVA S28-p
DFFA iso2 (human) CLLRRNYsREQHGVA S28-p
DFFA (mouse) CLLRRNHsRDQHGVA S28-p
DFFA iso2 (mouse) CLLRRNHSRDQHGVA S28
DFFA (rat) CLLRRNHSREQHGVA S28
S37-p
EQHGVAAsCLEDLRS
0 1
DFFA (human) EQHGVAAsCLEDLRS S37-p
DFFA iso2 (human) EQHGVAASCLEDLRS S37
DFFA (mouse) DQHGVAASSLEELRS S37
DFFA iso2 (mouse) DQHGVAASSLEELRS S37
DFFA (rat) EQHGVAASSLEELRS S37
K45
CLEDLRSKACDILAI
0 1
DFFA (human) CLEDLRSKACDILAI K45
DFFA iso2 (human) CLEDLRSKACDILAI K45
DFFA (mouse) SLEELRSkACELLAI K45-ac
DFFA iso2 (mouse) SLEELRSKACELLAI K45
DFFA (rat) SLEELRSKACELLAI K45
K45-ub
CLEDLRSkACDILAI
0 1
DFFA (human) CLEDLRSkACDILAI K45-ub
DFFA iso2 (human) CLEDLRSKACDILAI K45
DFFA (mouse) SLEELRSKACELLAI K45
DFFA iso2 (mouse) SLEELRSKACELLAI K45
DFFA (rat) SLEELRSKACELLAI K45
T68-p
LVLAEDGtIVDDDDy
0 2
DFFA (human) LVLAEDGtIVDDDDy T68-p
DFFA iso2 (human) LVLAEDGTIVDDDDy T68
DFFA (mouse) LVLAEDGTIVDDDDY T68
DFFA iso2 (mouse) LVLAEDGTIVDDDDY T68
DFFA (rat) LVLAEDGTIVDDEDY T68
Y75-p
tIVDDDDyFLCLPSN
0 32
DFFA (human) tIVDDDDyFLCLPSN Y75-p
DFFA iso2 (human) TIVDDDDyFLCLPSN Y75-p
DFFA (mouse) TIVDDDDYFLCLPSN Y75
DFFA iso2 (mouse) TIVDDDDYFLCLPSN Y75
DFFA (rat) TIVDDEDYFLCLPSN Y75
S107-p
DGGTAWIsQEsFDVD
Upstream
0 11
Treatment
  • UV
DFFA (human) DGGTAWIsQEsFDVD S107-p
DFFA iso2 (human) DGGTAWISQESFDVD S107
DFFA (mouse) DGGTAWVSQESFEAD S107
DFFA iso2 (mouse) DGGTAWVSQESFEAD S107
DFFA (rat) DGGTAWLSQEsFDTD S107
S110-p
TAWIsQEsFDVDETD
Upstream
0 5
Treatment
  • rapamycin
DFFA (human) TAWIsQEsFDVDETD S110-p
DFFA iso2 (human) TAWISQESFDVDETD S110
DFFA (mouse) TAWVSQESFEADEPD S110
DFFA iso2 (mouse) TAWVSQESFEADEPD S110
DFFA (rat) TAWLSQEsFDTDQTD S110-p
K189-ub
REEVRQSkQLLQLYL
0 1
DFFA (human) REEVRQSkQLLQLYL K189-ub
DFFA iso2 (human) REEVRQSKQLLQLYL K189
DFFA (mouse) REEARQSKQLLELYL K189
DFFA iso2 (mouse) REEARQSKQLLELYL K189
DFFA (rat) REEARQSKQLLELYL K189
K201-ub
LYLQALEkEGSLLSk
0 5
DFFA (human) LYLQALEkEGSLLSk K201-ub
DFFA iso2 (human) LYLQALEKEGSLLSK K201
DFFA (mouse) LYLQALEKEGNILSN K201
DFFA iso2 (mouse) LYLQALEKEGNILSN K201
DFFA (rat) LYLQALEKEGSILSN K201
K208-ub
kEGSLLSkQEESkAA
0 3
DFFA (human) kEGSLLSkQEESkAA K208-ub
DFFA iso2 (human) KEGSLLSKQEESKAA K208
DFFA (mouse) KEGNILSNQKESKAA N208
DFFA iso2 (mouse) KEGNILSNQKESKAA N208
DFFA (rat) KEGSILSNQNESKAA N208
K213-ub
LSkQEESkAAFGEEV
0 1
DFFA (human) LSkQEESkAAFGEEV K213-ub
DFFA iso2 (human) LSKQEESKAAFGEEV K213
DFFA (mouse) LSNQKESKAALSEEL K213
DFFA iso2 (mouse) LSNQKESKAALSEEL K213
DFFA (rat) LSNQNESKAALGEEL K213
S232-p
TGISRETssDVALAS
0 4
DFFA (human) TGISRETssDVALAS S232-p
DFFA iso2 (human) TGISRETSSDVALAS S232
DFFA (mouse) TGVGREMASEVLLRS A232
DFFA iso2 (mouse) TGVGREMASEVLLRS A232
DFFA (rat) TGVGGEVASEVMLRS A232
S233-p
GISRETssDVALASH
0 1
DFFA (human) GISRETssDVALASH S233-p
DFFA iso2 (human) GISRETSSDVALASH S233
DFFA (mouse) GVGREMASEVLLRSQ S233
DFFA iso2 (mouse) GVGREMASEVLLRSQ S233
DFFA (rat) GVGGEVASEVMLRSQ S233
T243-p
ALASHILtALREkQA
0 1
DFFA (human) ALASHILtALREkQA T243-p
DFFA iso2 (human) ALASHILTALREkQA T243
DFFA (mouse) LLRSQILTTLKEKPA T243
DFFA iso2 (mouse) LLRSQILTTLKEKPA T243
DFFA (rat) MLRSQILAALKEKPA A243
K248-ub
ILtALREkQAPELSL
0 2
DFFA (human) ILtALREkQAPELSL K248-ub
DFFA iso2 (human) ILTALREkQAPELSL K248-ub
DFFA (mouse) ILTTLKEKPAPELSL K248
DFFA iso2 (mouse) ILTTLKEKPAPELSL K248
DFFA (rat) ILAALKEKPAPELSL K248
S256
QAPELSLSsQDLELV
0 1
DFFA (human) QAPELSLSsQDLELV S256
DFFA iso2 (human) QAPELSLssQDLEVG S256-p
DFFA (mouse) PAPELSLSSQDLESV S256
DFFA iso2 (mouse) PAPELSLSSQDLEVG S256
DFFA (rat) PAPELSLSSQDLEVG S256
S257-p
APELSLSsQDLELVT
0 8
DFFA (human) APELSLSsQDLELVT S257-p
DFFA iso2 (human) APELSLssQDLEVGG S257-p
DFFA (mouse) APELSLSSQDLESVS S257
DFFA iso2 (mouse) APELSLSSQDLEVGK S257
DFFA (rat) APELSLSSQDLEVGK S257
R296-m1
CERELALrLQQTQsL
0 1
DFFA (human) CERELALrLQQTQsL R296-m1
DFFA iso2 (human) gap -
DFFA (mouse) CTTELALRLQQVQSL R296
DFFA iso2 (mouse) gap -
DFFA (rat) gap -
S302-p
LrLQQTQsLHSLRSI
0 1
DFFA (human) LrLQQTQsLHSLRSI S302-p
DFFA iso2 (human) gap -
DFFA (mouse) LRLQQVQSLHSLRNL S302
DFFA iso2 (mouse) gap -
DFFA (rat) gap -
S310-p
LHSLRSIsAskAsPP
0 3
DFFA (human) LHSLRSIsAskAsPP S310-p
DFFA iso2 (human) gap -
DFFA (mouse) LHSLRNLSARRsPLP S310
DFFA iso2 (mouse) gap -
DFFA (rat) gap -
S312-p
SLRSIsAskAsPPGD
0 4
DFFA (human) SLRSIsAskAsPPGD S312-p
DFFA iso2 (human) gap -
DFFA (mouse) SLRNLSARRsPLPGE R312
DFFA iso2 (mouse) gap -
DFFA (rat) gap -
K313-ub
LRSIsAskAsPPGDL
0 1
DFFA (human) LRSIsAskAsPPGDL K313-ub
DFFA iso2 (human) under review -
DFFA (mouse) under review -
DFFA iso2 (mouse) under review -
DFFA (rat) under review -
A314
RSIsAskAsPPGDLQ
0 16
DFFA (human) RSIsAskAsPPGDLQ A314
DFFA iso2 (human) gap -
DFFA (mouse) RNLSARRsPLPGEPQ S314-p
DFFA iso2 (mouse) gap -
DFFA (rat) gap -
S315-p
SIsAskAsPPGDLQN
Upstream
0 32
Treatment
  • EGF
  • LRRK2-IN-1
  • nocodazole
  • rapamycin
DFFA (human) SIsAskAsPPGDLQN S315-p
DFFA iso2 (human) gap -
DFFA (mouse) NLSARRsPLPGEPQR P315
DFFA iso2 (mouse) gap -
DFFA (rat) gap -
K324-ac
PGDLQNPkRARQDPT
0 14
DFFA (human) PGDLQNPkRARQDPT K324-ac
DFFA iso2 (human) gap -
DFFA (mouse) PGEPQRPKRAKRDSS K324
DFFA iso2 (mouse) gap -
DFFA (rat) gap -